XPhyto Therapeutics (CSE: XPHY-FSE:4XT) CEO Hugh Rogers sat down with Steve Darling from Proactive Vancouver to discuss an agreement with the brewing and beverage institute within the Technical University of Munich. Rogers reviews the structure of the deal and also talks about an agreement with Colombian cannabis giant PharmaCielo.
XPhyto kicks off exclusive partnership with brewing institute Weihenstephan
Quick facts: XPhyto Therapeutics Corp.
Price: 3.3 CAD
Market Cap: $179.04 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of XPhyto Therapeutics Corp. named herein, including the promotion by the Company of XPhyto Therapeutics Corp. in any Content on the Site, the...FOR OUR FULL DISCLAIMER CLICK HERE